Vara is dedicated to making data-driven breast cancer screening more accessible and effective worldwide. Their AI-assisted mammography platform supports the entire screening pathway, aiming to detect breast cancer early for better outcomes. They collaborate with leading physicians and have a proven clinical evidence base demonstrating their platform's positive impact on cancer detection and workload reduction.

They strive for early detection of deadly breast cancer globally to improve treatment effectiveness, reduce toxicity and costs, and save lives. Vara began as a spin-off from Merantix Venture Studio and has grown through close partnerships with screening centers and research institutions, continuously advancing their AI technology and expanding their international presence. Their software is CE marked and compliant with GDPR regulations.